Home Page

Voxmedia Program Image

         LDL-Cholesterol Lowering and Atherosclerotic
         Cardiovascular Disease Risk Reduction:
         Exploring the Evidence With Non-Statin Therapy

          Thursday, April 19, 2018

         Hilton New Orleans Riverside
         Grand Ballroom A
         Two Poydras Street
         New Orleans, Louisiana

         Dinner & Registration: 6:00 pm - 6:30 pm
         Symposium:  6:30 pm - 8:30 pm

Registration for this program is now closed.

Faculty:  Karol Watson, MD, PhD (Chair); Amit Khera, MD, MSc  Jennifer Robinson, MD, MPH; 
Program Overview:

In this program, lipid experts will present, in state-of-the-art lectures and in 'realworld' interactive cases, optimal strategies and provide 'take-home' messages for reducing risk in patients with elevated LDL-C.

This event is not a part of the official Internal Medicine Meeting 2018 Education Program.

Educational Objectives: 
Upon completion of this program, attendees should be able to:

  • Describe the relationship between LDL-C reduction and atherosclerotic cardiovascular disease risk reduction (ASCVD).
  • Identify patient populations that may benefit from the addition of non-statin cholesterollowering therapy for further reduction in LDL-C.
  • Discuss the clinical efficacy and safety profiles for ezetimibe and PCSK9 inhibitors.
  • Interpret the evidence from cardiovascular outcome trials with non-statin therapies that lower LDL-C in patients with ASCVD.
  • Indicate treatment recommendations in the 2017 Focused Update of the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-C Lowering in the Management of ASCVD Risk.
  • Explain best practices for lowering LDL-C and reducing ASCVD risk in patients with ASCVD, LDL-C ≥ 190 mg/dL, and statin intolerance.

    Free CME Here

    Target Audience:  This educational activity is intended for internists and other healthcare clinicians.

    Accreditation & Credit Designation Statements:
    Voxmedia LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
    Voxmedia LLC designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
    Nurse practitioners may participate in this educational activity and earn a certificate of completion as AANP accepts AMA PRA Category 1 Credits™ through its reciprocity agreements.
    The National Commission on Certification of Physician Assistants accepts AMA PRA Category 1 CreditsTM from organizations accredited by the ACCME.

    Educational Grant: Voxmedia International gratefully acknowledges the educational donation provided by Amgen.